Video Experimental Relacionado

Updated: Mar 31, 2026

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

Leucemia linfocítica crónica: mantener a raya la muerte celular

Klaus-Michael Debatin¹

¹Department of Pediatrics and Adolescent Medicine, University of Ulm, Eythstrasse 24, 89075, Ulm. klaus-michael.debatin@uniklinik-ulm.de

|June 2, 2007

Resumen

El estudio encontró que la disminución de la expresión del gen DAPK1 está relacionada con la leucemia linfocítica crónica (LLC). Esta regulación a la baja se produce a través de cambios genéticos y epigenéticos en las formas familiares y esporádicas de la enfermedad.

Área de la Ciencia:

Oncología Oncología.
Biología Molecular Biología Molecular
Genética La genética.

Sus antecedentes:

La leucemia linfocítica crónica (LLC) se caracteriza por la acumulación anormal de linfocitos B.
La comprensión de los mecanismos moleculares subyacentes a la patogénesis de la LLC es crucial para el desarrollo de terapias dirigidas.

Objetivo del estudio:

Investigar el papel de la expresión génica de DAPK1 en el desarrollo de la CLL.
Explorar los mecanismos genéticos y epigenéticos subyacentes a la regulación a la baja de DAPK1 en la LLC.

Principales métodos:

Análisis de los niveles de expresión génica de DAPK1 en pacientes con CLL.
Investigación de las alteraciones genéticas que afectan a DAPK1.1.
Evaluación de las modificaciones epigenéticas (por ejemplo, metilación) que afectan la expresión de DAPK1.

Principales resultados:

Se ha demostrado una regulación a la baja de la expresión de DAPK1 en CLL.
Se identificaron mecanismos genéticos y epigenéticos que contribuyen a la reducción de los niveles de DAPK1.
Se observaron estos cambios tanto en los casos familiares como en los casos esporádicos de CLL.

Conclusiones:

La regulación a la baja de DAPK1 está implicada en la patogénesis de la LLC.
Las alteraciones genéticas y epigenéticas de DAPK1 son relevantes tanto en la CLL familiar como en la esporádica.
DAPK1 puede representar un potencial objetivo terapéutico o diagnóstico en la CLL.

Más Videos Relacionados

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Videos de Conceptos Relacionados

Overview of Cell Death

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

Autophagic Cell Death

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...